Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE
 
Authors :  S. Lejon, J. F. Cramer, P. A. Nordberg
Date :  04 Oct 07  (Deposition) - 26 Feb 08  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.52
Chains :  Asym./Biol. Unit :  A,B
Keywords :  Lipid-Binding, Metal-Binding, Protein Binding, Peptidoglycan-Anchor, Bacterial Albumin-Binding, Disease Mutation, Three-Helix Bundle, Ga Module, Drug Binding, Glycoprotein, Cleavage On Pair Of Basic Residues, Human Serum Albumin, Secreted, Naproxen, Cell Wall, Glycation (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  S. Lejon, J. F. Cramer, P. A. Nordberg
Structural Basis For The Binding Of Naproxen To Human Serum Albumin In The Presence Of Fatty Acids And The Ga Module.
Acta Crystallogr. , Sect. F V. 64 64 2008
PubMed-ID: 18259051  |  Reference-DOI: 10.1107/S174430910706770X

(-) Compounds

Molecule 1 - SERUM ALBUMIN
    ChainsA
    FragmentRESIDUES 30-608
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymHUMAN SERUM ALBUMIN
    TissueSERUM
 
Molecule 2 - PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN
    ChainsB
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPET28
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    FragmentRESIDUES 213-265
    Organism ScientificPEPTOSTREPTOCOCCUS MAGNUS
    Organism Taxid1260
    SynonymGA MODULE

 Structural Features

(-) Chains, Units

  12
Asymmetric/Biological Unit AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 7)

Asymmetric/Biological Unit (2, 7)
No.NameCountTypeFull Name
1DKA6Ligand/IonDECANOIC ACID
2NPS1Ligand/Ion(2S)-2-(6-METHOXYNAPHTHALEN-2-YL)PROPANOICACID

(-) Sites  (7, 7)

Asymmetric Unit (7, 7)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREARG A:117 , TYR A:138 , ILE A:142 , TYR A:161 , ARG A:186 , NPS A:1591BINDING SITE FOR RESIDUE DKA A1585
2AC2SOFTWAREARG A:10 , TYR A:150 , LEU A:251 , ALA A:254 , ARG A:257 , ALA A:258 , LEU A:283 , SER A:287BINDING SITE FOR RESIDUE DKA A1586
3AC3SOFTWARESER A:342 , VAL A:344 , ARG A:348 , LEU A:387 , ARG A:485 , DKA A:1588BINDING SITE FOR RESIDUE DKA A1587
4AC4SOFTWAREARG A:410 , TYR A:411 , LEU A:460 , PHE A:488 , SER A:489 , DKA A:1587BINDING SITE FOR RESIDUE DKA A1588
5AC5SOFTWAREASP A:324 , GLU B:47BINDING SITE FOR RESIDUE DKA A1589
6AC6SOFTWARELEU A:238 , LEU A:260 , SER A:287 , ILE A:290 , ALA A:291BINDING SITE FOR RESIDUE DKA A1590
7AC7SOFTWAREHIS A:146 , PHE A:149 , LEU A:154 , PHE A:157 , TYR A:161 , ARG A:186 , GLY A:189 , DKA A:1585BINDING SITE FOR RESIDUE NPS A1591

(-) SS Bonds  (16, 16)

Asymmetric/Biological Unit
No.Residues
1A:75 -A:91
2A:90 -A:101
3A:124 -A:169
4A:168 -A:177
5A:200 -A:246
6A:245 -A:253
7A:265 -A:279
8A:278 -A:289
9A:316 -A:361
10A:360 -A:369
11A:392 -A:438
12A:437 -A:448
13A:461 -A:477
14A:476 -A:487
15A:514 -A:559
16A:558 -A:567

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2VDB)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (55, 55)

Asymmetric/Biological Unit (55, 55)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_010657F73YALBU_HUMANPolymorphism  ---AF49Y
02UniProtVAR_000507E84KALBU_HUMANPolymorphism77050410AE60K
03UniProtVAR_000508D87NALBU_HUMANPolymorphism78574148AD63N
04UniProtVAR_013011L90PALBU_HUMANDisease (FDAH)77892378AL66P
05UniProtVAR_014290E121GALBU_HUMANPolymorphism  ---AE97G
06UniProtVAR_000510R138GALBU_HUMANPolymorphism77238412AR114G
07UniProtVAR_000511E143KALBU_HUMANPolymorphism75522063AE119K
08UniProtVAR_013012V146EALBU_HUMANPolymorphism77752336AV122E
09UniProtVAR_000512H152RALBU_HUMANPolymorphism80095457AH128R
10UniProtVAR_000513C201FALBU_HUMANPolymorphism77656691AC177F
11UniProtVAR_014291A215TALBU_HUMANPolymorphism3210154AA191T
12UniProtVAR_014292A215VALBU_HUMANPolymorphism3204504AA191V
13UniProtVAR_014293Q220LALBU_HUMANPolymorphism3210163AQ196L
14UniProtVAR_000514R242HALBU_HUMANDisease (FDAH)75002628AR218H
15UniProtVAR_013013R242PALBU_HUMANDisease (FDAH)75002628AR218P
16UniProtVAR_000515K249QALBU_HUMANPolymorphism79804069AK225Q
17UniProtVAR_000516K264EALBU_HUMANPolymorphism79377490AK240E
18UniProtVAR_000517Q292RALBU_HUMANPolymorphism80002911AQ268R
19UniProtVAR_000518D293GALBU_HUMANPolymorphism79744198AD269G
20UniProtVAR_000519K300NALBU_HUMANPolymorphism74718349AK276N
21UniProtVAR_000520K337NALBU_HUMANPolymorphism72552710AK313N
22UniProtVAR_013014D338GALBU_HUMANPolymorphism76242087AD314G
23UniProtVAR_013015D338VALBU_HUMANPolymorphism76242087AD314V
24UniProtVAR_000521N342KALBU_HUMANPolymorphism77544362AN318K
25UniProtVAR_000522A344TALBU_HUMANPolymorphism78953271AA320T
26UniProtVAR_000523E345KALBU_HUMANPolymorphism72552711AE321K
27UniProtVAR_000524E357KALBU_HUMANPolymorphism77354753AE333K
28UniProtVAR_000525E378KALBU_HUMANPolymorphism76593094AE354K
29UniProtVAR_000526E382KALBU_HUMANPolymorphism75791663AE358K
30UniProtVAR_013016K383NALBU_HUMANPolymorphism75069738AK359N
31UniProtVAR_000527D389HALBU_HUMANPolymorphism77187142AD365H
32UniProtVAR_000528D389VALBU_HUMANPolymorphism78538497AD365V
33UniProtVAR_000529K396EALBU_HUMANPolymorphism78166690AK372E
34UniProtVAR_000530D399NALBU_HUMANPolymorphism77514449AD375N
35UniProtVAR_000531E400KALBU_HUMANPolymorphism79047363AE376K
36UniProtVAR_000532E400QALBU_HUMANPolymorphism79047363AE376Q
37UniProtVAR_000533E406KALBU_HUMANPolymorphism76483862AE382K
38UniProtVAR_014294E420KALBU_HUMANPolymorphism  ---AE396K
39UniProtVAR_013017R434CALBU_HUMANPolymorphism78575701AR410C
40UniProtVAR_014295K490EALBU_HUMANPolymorphism1063469AK466E
41UniProtVAR_000534E503KALBU_HUMANPolymorphism80259813AE479K
42UniProtVAR_000535D518NALBU_HUMANPolymorphism75920790AD494N
43UniProtVAR_000536E525KALBU_HUMANPolymorphism75523493AE501K
44UniProtVAR_000537E529KALBU_HUMANPolymorphism74826639AE505K
45UniProtVAR_013018V557MALBU_HUMANPolymorphism78284052AV533M
46UniProtVAR_000538K560EALBU_HUMANPolymorphism77645174AK536E
47UniProtVAR_000539K565EALBU_HUMANPolymorphism80345158AK541E
48UniProtVAR_000541D574AALBU_HUMANPolymorphism79738788AD550A
49UniProtVAR_000540D574GALBU_HUMANPolymorphism79738788AD550G
50UniProtVAR_013019K584EALBU_HUMANPolymorphism76671808AK560E
51UniProtVAR_000542D587NALBU_HUMANPolymorphism76587671AD563N
52UniProtVAR_000543E589KALBU_HUMANPolymorphism75709682AE565K
53UniProtVAR_000544E594KALBU_HUMANPolymorphism79228041AE570K
54UniProtVAR_000545K597EALBU_HUMANPolymorphism80106970AK573E
55UniProtVAR_000546K598NALBU_HUMANPolymorphism75738598AK574N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 5)

Asymmetric/Biological Unit (2, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ALBUMIN_2PS51438 Albumin domain profile.ALBU_HUMAN19-210
211-403
404-601
  2-
A:187-379
A:380-577
2ALBUMIN_1PS00212 Albumin domain signature.ALBU_HUMAN185-209
377-401
575-599
  3A:161-185
A:353-377
A:551-575

(-) Exons   (13, 13)

Asymmetric/Biological Unit (13, 13)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.2aENST000002958972aENSE00002075693chr4:74269956-74270123168ALBU_HUMAN1-27270--
1.3aENST000002958973aENSE00001076782chr4:74270833-7427089058ALBU_HUMAN27-46201A:6-2217
1.4bENST000002958974bENSE00001076799chr4:74272346-74272478133ALBU_HUMAN46-90451A:22-6645
1.5aENST000002958975aENSE00001076811chr4:74274311-74274522212ALBU_HUMAN91-161711A:67-137 (gaps)71
1.7dENST000002958977dENSE00001076808chr4:74275072-74275204133ALBU_HUMAN161-205451A:137-18145
1.8aENST000002958978aENSE00001076797chr4:74276029-7427612698ALBU_HUMAN206-238331A:182-21433
1.9aENST000002958979aENSE00001076788chr4:74277713-74277842130ALBU_HUMAN238-281441A:214-25744
1.10bENST0000029589710bENSE00001076792chr4:74279137-74279351215ALBU_HUMAN282-353721A:258-32972
1.11aENST0000029589711aENSE00001076805chr4:74280752-74280884133ALBU_HUMAN353-397451A:329-37345
1.12ENST0000029589712ENSE00001076781chr4:74281973-7428207098ALBU_HUMAN398-430331A:374-40633
1.13bENST0000029589713bENSE00001076796chr4:74283248-74283386139ALBU_HUMAN430-476471A:406-45247
1.14bENST0000029589714bENSE00001076790chr4:74283805-74284028224ALBU_HUMAN477-551751A:453-52775
1.16bENST0000029589716bENSE00001076802chr4:74285224-74285356133ALBU_HUMAN551-595451A:527-57145
1.18aENST0000029589718aENSE00001076795chr4:74285971-7428603868ALBU_HUMAN596-609141A:572-58413
1.20jENST0000029589720jENSE00001823230chr4:74286809-74287129321ALBU_HUMAN-00--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:574
 aligned with ALBU_HUMAN | P02768 from UniProtKB/Swiss-Prot  Length:609

    Alignment length:579
                                    39        49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529       539       549       559       569       579       589       599         
           ALBU_HUMAN    30 EVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG 608
               SCOP domains d2vdba3 A:6-196 automated matches                                                                                                                                                              d2vdba1 A:197-388 automated matches                                                                                                                                                             d2vdba2 A:389-584 automated matches                                                                                                                                                                  SCOP domains
               CATH domains 2vdbA01 A:6-107  [code=1.10.246.10, no name defined]                                                  2vdbA02 A:108-197  [code=1.10.246.10, no name defined]                                    -------2vdbA03 A:205-296  [code=1.10.246.10, no name defined]                                      2vdbA04 A:297-382  [code=1.10.246.10, no name defined]                                2vdbA05 A:383-494  [code=1.10.246.10, no name defined]                                                          2vdbA06 A:495-574  [code=1.10.246.10, no name defined]                          ---------- CATH domains
           Pfam domains (1) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2vdbA01 A:388-568                                                                                                                                                      ---------------- Pfam domains (1)
           Pfam domains (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2vdbA02 A:388-568                                                                                                                                                      ---------------- Pfam domains (2)
           Pfam domains (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2vdbA03 A:388-568                                                                                                                                                      ---------------- Pfam domains (3)
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhh...................hhhhhhhhhh......-----hhhhh........hhhhhhhh............hhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhh..hhhhhh.hhhhhhhhhhh............hhhhhh...hhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhh.hhhhhhhhhhh............hhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhh... Sec.struct. author
             SAPs(SNPs) (1) -------------------------------------------Y----------K--N--P------------------------------G----------------G----K--E-----R------------------------------------------------F-------------T----L---------------------H------Q--------------E---------------------------RG------N------------------------------------NG---K-TK-----------K--------------------K---KN-----H------E--NK-----K-------------K-------------C-------------------------------------------------------E------------K--------------N------K---K---------------------------M--E----E--------A---------E--N-K----K--EN---------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------V--------------------------P-----------------------------------------------------------------------------------------------V--------------------------------------------------V----------Q-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G---------------------------------- SAPs(SNPs) (2)
                PROSITE (1) ALBUMIN_2  PDB: - UniProt: 19-210                                                                                                                                                    ALBUMIN_2  PDB: A:187-379 UniProt: 211-403                                                                                                                                                       ALBUMIN_2  PDB: A:380-577 UniProt: 404-601                                                                                                                                                            ------- PROSITE (1)
                PROSITE (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:161-185-----------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:353-377-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:551-575--------- PROSITE (2)
           Transcript 1 (1) Exon 1.3a        --------------------------------------------Exon 1.5a  PDB: A:67-137 (gaps) UniProt: 91-161                        --------------------------------------------Exon 1.8a  PDB: A:182-214        -------------------------------------------Exon 1.10b  PDB: A:258-329 UniProt: 282-353                             --------------------------------------------Exon 1.12  PDB: A:374-406        ----------------------------------------------Exon 1.14b  PDB: A:453-527 UniProt: 477-551                                --------------------------------------------Exon 1.18a    Transcript 1 (1)
           Transcript 1 (2) ----------------Exon 1.4b  PDB: A:22-66 UniProt: 46-90       ----------------------------------------------------------------------Exon 1.7d  PDB: A:137-181 UniProt: 161-205   --------------------------------Exon 1.9a  PDB: A:214-257 UniProt: 238-281  -----------------------------------------------------------------------Exon 1.11a  PDB: A:329-373 UniProt: 353-397  --------------------------------Exon 1.13b  PDB: A:406-452 UniProt: 430-476    --------------------------------------------------------------------------Exon 1.16b  PDB: A:527-571 UniProt: 551-595  ------------- Transcript 1 (2)
                 2vdb A   6 EVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATL-----EMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG 584
                                    15        25        35        45        55        65        75    |    -|       95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455       465       475       485       495       505       515       525       535       545       555       565       575         
                                                                                                     80    86                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

Chain B from PDB  Type:PROTEIN  Length:55
 aligned with PAB_FINMA | Q51911 from UniProtKB/Swiss-Prot  Length:387

    Alignment length:55
                                   220       230       240       250       260     
            PAB_FINMA   211 KMTIDQWLLKNAKEDAIAELKKAGITSDFYFNAINKAKTVEEVNALKNEILKAHA 265
               SCOP domains d2vdbb_ B: automated matches                            SCOP domains
               CATH domains 2vdbB00 B:-1-53 Albumin-binding domain                  CATH domains
               Pfam domains ------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhh.hhhhhhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------- SAPs(SNPs)
                    PROSITE ------------------------------------------------------- PROSITE
                 Transcript ------------------------------------------------------- Transcript
                 2vdb B  -1 HMTIDQWLLKNAKEDAIAELKKAGITSDFYFNAINKAKTVEEVNALKNEILKAHA  53
                                     8        18        28        38        48     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 4)

Asymmetric/Biological Unit

(-) CATH Domains  (2, 7)

Asymmetric/Biological Unit

(-) Pfam Domains  (1, 3)

Asymmetric/Biological Unit

(-) Gene Ontology  (47, 48)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (ALBU_HUMAN | P02768)
molecular function
    GO:0003677    DNA binding    Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
    GO:0016209    antioxidant activity    Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
    GO:0051087    chaperone binding    Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
    GO:0005507    copper ion binding    Interacting selectively and non-covalently with copper (Cu) ions.
    GO:0008144    drug binding    Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0005504    fatty acid binding    Interacting selectively and non-covalently with fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0008289    lipid binding    Interacting selectively and non-covalently with a lipid.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0019825    oxygen binding    Interacting selectively and non-covalently with oxygen (O2).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0030170    pyridoxal phosphate binding    Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
    GO:0015643    toxic substance binding    Interacting selectively and non-covalently with a toxic substance, a poisonous substance that causes damage to biological systems.
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0015721    bile acid and bile salt transport    The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0098869    cellular oxidant detoxification    Any process carried out at the cellular level that reduces or removes the toxicity superoxide radicals or hydrogen peroxide.
    GO:0009267    cellular response to starvation    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
    GO:0019836    hemolysis by symbiont of host erythrocytes    The cytolytic destruction of red blood cells, with the release of intracellular hemoglobin, in the host organism by a symbiont. The host is defined as the larger of the organisms involved in a symbiotic interaction.
    GO:0042157    lipoprotein metabolic process    The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
    GO:0051659    maintenance of mitochondrion location    Any process in which a mitochondrion is maintained in a specific location within a cell and prevented from moving elsewhere.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0043069    negative regulation of programmed cell death    Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0046010    positive regulation of circadian sleep/wake cycle, non-REM sleep    Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep.
    GO:0006898    receptor-mediated endocytosis    An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
    GO:0046689    response to mercury ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
    GO:0007584    response to nutrient    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
    GO:0010033    response to organic substance    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
    GO:0070541    response to platinum ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platinum stimulus.
    GO:0001895    retina homeostasis    A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
    GO:0043252    sodium-independent organic anion transport    The directed, sodium-independent, movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0006810    transport    The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0005604    basement membrane    A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0043209    myelin sheath    An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.
    GO:0043234    protein complex    A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

Chain B   (PAB_FINMA | Q51911)
biological process
    GO:0009405    pathogenesis    The set of specific processes that generate the ability of an organism to induce an abnormal, generally detrimental state in another organism.
cellular component
    GO:0005618    cell wall    The rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal, most prokaryotic cells and some protozoan parasites, maintaining their shape and protecting them from osmotic lysis. In plants it is made of cellulose and, often, lignin; in fungi it is composed largely of polysaccharides; in bacteria it is composed of peptidoglycan; in protozoan parasites such as Giardia species, it's made of carbohydrates and proteins.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    DKA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NPS  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2vdb)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2vdb
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ALBU_HUMAN | P02768
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  PAB_FINMA | Q51911
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  615999
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ALBU_HUMAN | P02768
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  PAB_FINMA | Q51911
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ALBU_HUMAN | P027681ao6 1bj5 1bke 1bm0 1e78 1e7a 1e7b 1e7c 1e7e 1e7f 1e7g 1e7h 1e7i 1gni 1gnj 1h9z 1ha2 1hk1 1hk2 1hk3 1hk4 1hk5 1n5u 1o9x 1tf0 1uor 1ysx 2bx8 2bxa 2bxb 2bxc 2bxd 2bxe 2bxf 2bxg 2bxh 2bxi 2bxk 2bxl 2bxm 2bxn 2bxo 2bxp 2bxq 2esg 2i2z 2i30 2n0x 2vue 2vuf 2xsi 2xvq 2xvu 2xvv 2xvw 2xw0 2xw1 2ydf 3a73 3b9l 3b9m 3cx9 3jqz 3jry 3lu6 3lu7 3lu8 3sqj 3tdl 3uiv 4bke 4e99 4emx 4g03 4g04 4hgk 4hgm 4iw1 4iw2 4k2c 4k71 4l8u 4l9k 4l9q 4la0 4lb2 4lb9 4n0f 4n0u 4s1y 4z69 5fuo 5id7 5ifo 5ijf 5ujb 5x52
        PAB_FINMA | Q519111gab 1prb 1tf0 2j5y

(-) Related Entries Specified in the PDB File

1ao6 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1bj5 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1bke HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID
1bm0 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e78 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e7a CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
1e7b CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE
1e7c HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
1e7e HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID
1e7f HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID
1e7g HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1e7h HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID
1e7i HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID
1gab STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR , 20 STRUCTURES
1gni HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC ACID)
1gnj HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
1h9z HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
1ha2 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) ENANTIOMER OF WARFARIN
1hk1 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1hk2 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- THYRONINE)
1hk3 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- THYRONINE)
1hk4 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1hk5 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1n5u X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
1o9x HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
1prb STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR , MINIMIZED AVERAGE STRUCTURE
1tf0 CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMANSERUM ALBUMIN
1uor X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
1ysx SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMINCOMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2
2bx8 HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
2bxa HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY -4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID ( CMPF)
2bxb HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
2bxc HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
2bxd HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
2bxe HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
2bxf HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
2bxg HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
2bxh HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
2bxi HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
2bxk HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , AZAPROPAZONE AND INDOMETHACIN
2bxl HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5-DIIODOSALICYLIC ACID
2bxm HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
2bxn HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
2bxo HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
2bxp HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
2bxq HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , PHENYLBUTAZONE AND INDOMETHACIN
2esg SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULINIGA1 AND HUMAN SERUM ALBUMIN
2j5y CRYSTAL STRUCTURE OF THE GA MODULE FROM F .MAGNA